Inhibitor Therapeutics, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2014 to 2023.
  • Inhibitor Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -70.6 %, a 150% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Return On Equity for 2023 was -45.5 %, a 96.8% increase from 2022.
  • Inhibitor Therapeutics, Inc. annual Return On Equity for 2022 was -1.43K %, a 16907% decline from 2021.
  • Inhibitor Therapeutics, Inc. annual Return On Equity for 2021 was 8.49 %, a 74% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -45.5 +1.38K +96.8% Jan 1, 2023 Dec 31, 2023
2022 -1.43K -1.44K -16907% Jan 1, 2022 Dec 31, 2022
2021 8.49 -24.2 -74% Jan 1, 2021 Dec 31, 2021
2020 32.7 -145 -81.6% Jan 1, 2020 Dec 31, 2020
2019 178 -179 -50.1% Jan 1, 2019 Dec 31, 2019
2018 356 +740 Jan 1, 2018 Dec 31, 2018
2017 -383 -189 -97.1% Jan 1, 2017 Dec 31, 2017
2016 -194 +376 +65.9% Jan 1, 2016 Dec 31, 2016
2015 -570 -2.07K -138% Jan 1, 2015 Dec 31, 2015
2014 1.5K Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.